XML 26 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Cash Flow From Operating Activities:      
Net income $ 96,070 $ 81,051 $ 65,384
Adjustments to reconcile net income to net cash provided by operating activities:      
Provision for loan losses 9,143 5,657 417
Depreciation and amortization 7,967 7,161 6,262
Change in deferred taxes 15,523 8,611 4,444
Share-based compensation 2,827 2,600 2,270
Loans originated for sale (377,252) (354,265) (364,411)
Proceeds from sales of loans held for sale 387,095 367,148 367,377
Gains on sales of loans held for sale (5,910) (5,918) (5,625)
Gain on the sale of insurance subsidiary 8,265
Gain on cancellation of subordinated debentures (1,250)
Gains on sales of securities available for sale (2,631) (3,389) (2,670)
Increase in cash surrender of life insurance (3,906) (3,630) (2,927)
Gains on life insurance benefits (2,671) (643)
Change in interest receivable (6,838) (1,779) (2,833)
Change in interest payable 31 18 (162)
Other adjustments 7,054 1,097 (1,351)
Net cash provided by operating activities 126,502 103,719 56,660
Cash Flows from Investing Activities:      
Net change in interest-bearing deposits 237,936 7,856 24,917
Purchases of:      
Securities available for sale (479,045) (281,470) (200,154)
Securities held to maturity (30,220) (110,797) (87,282)
Proceeds from sales of securities available for sale 94,165 167,186 83,647
Proceeds from maturities of:      
Securities available for sale 70,846 73,956 63,124
Securities held to maturity 72,220 119,052 98,581
Redemption (Purchase) of Federal Reserve and Federal Home Loan Bank stock 40 19,669 7,268
Net change in loans (670,000) (452,781) (350,287)
Net cash and cash equivalents received (paid) in acquisition 54,536 (7,936)
Net cash received from sale of insurance subsidiary 15,155
Proceeds from the sale of other real estate owned 6,584 9,974 12,567
Proceeds from life insurance benefits 11,655 3,141
Other investing activities (4,047) (4,490) 9
Net cash used in investing activities (635,330) (448,704) (340,391)
Net change in :      
Demand and savings deposits 425,742 332,600 240,736
Certificates of deposit and other time deposits 75,236 (66,920) (79,656)
Borrowings 1,088,189 1,107,795 491,660
Repayment of borrowings (1,024,166) (982,449) (370,813)
Cash dividends on common stock (31,820) (22,203) (15,654)
Stock issued under employee benefit plans 519 462 460
Stock issued under dividend reinvestment and stock purchase plans 991 835 661
Stock options exercised 2,398 2,602 1,531
Stock redeemed (1,283) (1,980) (1,640)
Net cash provided by financing activities 535,806 370,742 267,285
Net Change in Cash and Cash Equivalents 26,978 25,757 (16,446)
Cash and Cash Equivalents, beginning of the year 127,927 102,170 118,616
Cash and Cash Equivalents, end of year 154,905 127,927 102,170
Additional cash flow information:      
Interest paid 36,332 26,821 24,903
Income tax paid 22,421 11,999 21,200
Loans transferred to other real estate owned 8,360 1,684 3,644
Fixed assets transferred to other assets 6,753 360 1,600
Non-cash investing activities using trade date accounting 9,401 14,179 1,559
Liabilities assumed in conjunction with acquisitions      
Fair value of assets acquired 1,531,397 0 635,047
Cash received (paid) in acquisition (12) (14,500)
Less: Common stock issued 321,431 70,402
Liabilities assumed $ 1,209,954 $ 0 $ 550,145